Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Boston Scientific Corporation

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Boston Scientific (BSX), Resmed (RMD) and HCA Health...

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Resmed (RMD) and HCA Healthcare (HCA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cochlear (CHEOF) and Boston Scientific (BSX). Cochlear (CHEOF) In...

Analysts Offer Insights on Healthcare Companies: Cochlear (OtherCHEOF) and Boston Scientific (BSX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molina Healthcare (MOH), Boston Scientific (BSX) a...

Analysts Conflicted on These Healthcare Names: Molina Healthcare (MOH), Boston Scientific (BSX) and Praxis Precision Medicines (PRAX)

Traders will find all of the hottest stock market stories for Wednesday in our daily wrap-up.


Morning News Wrap-Up, 4/22/26: Today’s Biggest Stock Market Stories!

The stock of Boston Scientific ($BSX) is up 10% on April 22 after the medical device maker issued financial results that topped Wall Street’s forec...

Here’s Why Boston Scientific Stock (BSX) Is Up 10% Today

The Vanguard S&P 500 ETF&nbsp;($VOO), which tracks the S&P 500 Index&nbsp;(SPX), rose 0.26% in pre-market trading on Tuesday as investors focused o...

Why Is Vanguard S&P 500 ETF (VOO) Up Today, 4/21/2026?

A class action lawsuit was filed against medical device company Boston Scientific ($BSX) on March 5, 2026. Plaintiffs -shareholders- in the federal...

Shareholders Sue Boston Scientific Over Heart Device Growth Claims

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Boston Scientific (BSX) has launched the Respiration Measured Via End...

Boston Scientific’s RESPI Study Signals Quiet Push Into Smart Respiratory Monitoring

Boston Scientific ($BSX) announced an update on their ongoing clinical study. The Fainting Detection And Early Warning In Syncope Evaluation Study ...

Boston Scientific Advances Fainting Detection Study With New Wearable Data Initiative

Blackstone Minerals Ltd ( ($AU:BSX) ) just unveiled an announcement. Blackstone Minerals Limited has announced the cessation of several tranches of...

Blackstone Minerals Options Lapse, Trimming Potential Future Dilution

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Belite Bio, Inc. ADR (BLTE), Allogene Therapeutics (...

Wall Street Analysts Are Bullish on Top Healthcare Picks

In a report released on April 2, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Boston Scientific, with a price target of $115.00....

Boston Scientific (BSX) Receives a Buy from RBC Capital

In a report released yesterday, Hans Engel from Erste Group assigned a Hold rating to Boston Scientific. The company’s shares closed today at $62.0...

Boston Scientific (BSX) Gets a Hold from Erste Group

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Alto Neuroscience, Inc. ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BSX	$56.91	-1.22%	10.03M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BSX	$56.91	-1.2%	10.03M
3
4
5
6

BSX

BSX

Get Boston Scientific Corporation Data in Excel

Get Boston Scientific Corporation Data in Excel